One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
NCT04148820
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Heart Disease
Interventions
DRUG:
Aspirin, Atorvastatin, Perindopril
Sponsor
University of Roma La Sapienza